AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41
LIVE ATTENUATED SIMIAN IMMUNODEFICIENCY VIRUS (SIV)MAC IN MACAQUES CAN INDUCE PROTECTION AGAINST MUCOSAL INFECTION WITH SIVSM
Authors: NILSSON C MAKITALO B THORSTENSSON R NORLEY S BINNINGERSCHINZEL D CRANAGE M RUD E BIBERFELD G PUTKONEN P
Citation: C. Nilsson et al., LIVE ATTENUATED SIMIAN IMMUNODEFICIENCY VIRUS (SIV)MAC IN MACAQUES CAN INDUCE PROTECTION AGAINST MUCOSAL INFECTION WITH SIVSM, AIDS, 12(17), 1998, pp. 2261-2270
IMMUNE-RESPONSES BUT NO PROTECTION AGAINST SHIV BY GENE-GUN DELIVERY OF HIV-1 DNA FOLLOWED BY RECOMBINANT SUBUNIT PROTEIN BOOSTS
Authors: PUTKONEN P QUESADAROLANDER M LEANDERSSON AC SCHWARTZ S THORSTENSSON R OKUDA K WAHREN B HINKULA J
Citation: P. Putkonen et al., IMMUNE-RESPONSES BUT NO PROTECTION AGAINST SHIV BY GENE-GUN DELIVERY OF HIV-1 DNA FOLLOWED BY RECOMBINANT SUBUNIT PROTEIN BOOSTS, Virology (New York, N.Y. Print), 250(2), 1998, pp. 293-301
LYMPHOMA DEVELOPMENT IN SIV-INFECTED MONKEYS
Authors: BIBERFELD P LI SL KAAYA EE FEICHTINGER H REZIKYAN S CASTANOSVELEZ E PUTKONEN P BIBERFELD G
Citation: P. Biberfeld et al., LYMPHOMA DEVELOPMENT IN SIV-INFECTED MONKEYS, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 141-141
OUTCOME OF IMMUNIZATION OF CYNOMOLGUS MONKEYS WITH RECOMBINANT SEMLIKI-FOREST-VIRUS ENCODING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE PROTEIN AND CHALLENGE WITH A HIGH-DOSE OF SHIV-4 VIRUS
Authors: BERGLUND P QUESADAROLANDER M PUTKONEN P BIBERFELD G THORSTENSSON R LILJESTROM P
Citation: P. Berglund et al., OUTCOME OF IMMUNIZATION OF CYNOMOLGUS MONKEYS WITH RECOMBINANT SEMLIKI-FOREST-VIRUS ENCODING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE PROTEIN AND CHALLENGE WITH A HIGH-DOSE OF SHIV-4 VIRUS, AIDS research and human retroviruses, 13(17), 1997, pp. 1487-1495
PREVENTION OF SIMIAN IMMUNODEFICIENCY VIRUS, SIVSM, OR HIV-2 INFECTION IN CYNOMOLGUS MONKEYS BY PREEXPOSURE AND POSTEXPOSURE ADMINISTRATIONOF BEA-005
Authors: BOTTIGER D JOHANSSON NG SAMUELSSON B ZHANG H PUTKONEN P VRANG L OBERG B
Citation: D. Bottiger et al., PREVENTION OF SIMIAN IMMUNODEFICIENCY VIRUS, SIVSM, OR HIV-2 INFECTION IN CYNOMOLGUS MONKEYS BY PREEXPOSURE AND POSTEXPOSURE ADMINISTRATIONOF BEA-005, AIDS, 11(2), 1997, pp. 157-162
PROTECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 2-EXPOSED SERONEGATIVE MACAQUES FROM MUCOSAL SIMIAN IMMUNODEFICIENCY VIRUS TRANSMISSION
Authors: PUTKONEN P MAKITALO B BOTTIGER D BIBERFELD G THORSTENSSON R
Citation: P. Putkonen et al., PROTECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 2-EXPOSED SERONEGATIVE MACAQUES FROM MUCOSAL SIMIAN IMMUNODEFICIENCY VIRUS TRANSMISSION, Journal of virology, 71(7), 1997, pp. 4981-4984
SIV INFECTION OF MONKEY SPLEEN-CELLS INCLUDING FOLLICULAR DENDRITIC CELLS IN DIFFERENT STAGES OF DISEASE
Authors: STAHMER I ORDONEZ C POPOVIC M MESQUITA R EKMAN M ALBERT J PUTKONEN P BOTTIGER D BIBERFELD G BIBERFELD P
Citation: I. Stahmer et al., SIV INFECTION OF MONKEY SPLEEN-CELLS INCLUDING FOLLICULAR DENDRITIC CELLS IN DIFFERENT STAGES OF DISEASE, Journal of acquired immune deficiency syndromes and human retrovirology, 11(1), 1996, pp. 1-9
INHIBITION OF SIV AND HIV-2 REPLICATION IN CYNOMOLGUS MONKEYS BY (-)9-[4-HYDROXY-2-(HYDROXYMETHYL)BUTYL]GUANINE (H2G)
Authors: BOTTIGER D JOHANSSON NG LIND P LINDBORG B NOREEN R PUTKONEN P VRANG L WAHREN B OBERG B
Citation: D. Bottiger et al., INHIBITION OF SIV AND HIV-2 REPLICATION IN CYNOMOLGUS MONKEYS BY (-)9-[4-HYDROXY-2-(HYDROXYMETHYL)BUTYL]GUANINE (H2G), Antiviral chemistry & chemotherapy, 7(1), 1996, pp. 21-26
PROTECTION AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 AND SIMIAN IMMUNODEFICIENCY VIRUS IN MACAQUES VACCINATED AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2
Authors: BIBERFELD G THORSTENSSON R PUTKONEN P
Citation: G. Biberfeld et al., PROTECTION AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 AND SIMIAN IMMUNODEFICIENCY VIRUS IN MACAQUES VACCINATED AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2, AIDS research and human retroviruses, 12(5), 1996, pp. 443-446
NESTED POLYMERASE CHAIN-REACTION PRIMERS THAT DISTINGUISH BETWEEN SIVSM AND HIV TYPE-2
Authors: WALTHER L GRANKVIST O PUTKONEN P BIBERFELD G THORSTENSSON R
Citation: L. Walther et al., NESTED POLYMERASE CHAIN-REACTION PRIMERS THAT DISTINGUISH BETWEEN SIVSM AND HIV TYPE-2, AIDS research and human retroviruses, 12(12), 1996, pp. 1077-1079
PROTECTION AGAINST MUCOSAL SIVSM CHALLENGE IN MACAQUES INFECTED WITH A CHIMERIC SIV THAT EXPRESSES HIV TYPE-1 ENVELOPE
Authors: QUESADAROLANDER M MAKITALO B THORSTENSSON R ZHANG YJ CASTANOSVELEZ E BIBERFELD G PUTKONEN P
Citation: M. Quesadarolander et al., PROTECTION AGAINST MUCOSAL SIVSM CHALLENGE IN MACAQUES INFECTED WITH A CHIMERIC SIV THAT EXPRESSES HIV TYPE-1 ENVELOPE, AIDS research and human retroviruses, 12(11), 1996, pp. 993-999
BROAD CROSS-NEUTRALIZING ACTIVITY IN SERUM IS ASSOCIATED WITH SLOW PROGRESSION AND LOW-RISK OF TRANSMISSION IN PRIMATE LENTIVIRUS INFECTIONS
Authors: FENYO EM PUTKONEN P
Citation: Em. Fenyo et P. Putkonen, BROAD CROSS-NEUTRALIZING ACTIVITY IN SERUM IS ASSOCIATED WITH SLOW PROGRESSION AND LOW-RISK OF TRANSMISSION IN PRIMATE LENTIVIRUS INFECTIONS, Immunology letters, 51(1-2), 1996, pp. 95-99
IMMUNOGENICITY AND PROTECTIVE EFFICACY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 RECOMBINANT CANARYPOX (ALVAC) VACCINE CANDIDATE IN CYNOMOLGUS MONKEYS
Authors: ANDERSSON S MAKITALO B THORSTENSSON R FRANCHINI G TARTAGLIA J LIMBACH K PAOLETTI E PUTKONEN P BIBERFELD G
Citation: S. Andersson et al., IMMUNOGENICITY AND PROTECTIVE EFFICACY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 RECOMBINANT CANARYPOX (ALVAC) VACCINE CANDIDATE IN CYNOMOLGUS MONKEYS, The Journal of infectious diseases, 174(5), 1996, pp. 977-985
LONG-TERM PROTECTION AGAINST SIV-INDUCED DISEASE IN MACAQUES VACCINATED WITH A LIVE ATTENUATED HIV-2 VACCINE
Authors: PUTKONEN P WALTHER L ZHANG YJ LI SL NILSSON C ALBERT J BIBERFELD P THORSTENSSON R BIBERFELD G
Citation: P. Putkonen et al., LONG-TERM PROTECTION AGAINST SIV-INDUCED DISEASE IN MACAQUES VACCINATED WITH A LIVE ATTENUATED HIV-2 VACCINE, Nature medicine, 1(9), 1995, pp. 914-918
THYMIC IMMUNOPATHOLOGY AND PROGRESSION OF SIVSM INFECTION IN CYNOMOLGUS MONKEYS
Authors: LI SL KAAYA EE ORDONEZ C EKMAN M FEICHTINGER H PUTKONEN P BOTTIGER D BIBERFELD G BIBERFELD P
Citation: Sl. Li et al., THYMIC IMMUNOPATHOLOGY AND PROGRESSION OF SIVSM INFECTION IN CYNOMOLGUS MONKEYS, Journal of acquired immune deficiency syndromes and human retrovirology, 9(1), 1995, pp. 1-10
EVALUATION OF HIV-1 HIV-2 IMMUNOBLOTS FOR DETECTION OF HIV-2 ANTIBODIES
Authors: WALTHER L PUTKONEN P DIAS F BIBERFELD G THORSTENSSON R
Citation: L. Walther et al., EVALUATION OF HIV-1 HIV-2 IMMUNOBLOTS FOR DETECTION OF HIV-2 ANTIBODIES, Clinical and diagnostic virology, 4(1), 1995, pp. 67-79
PROTECTIVE IMMUNITY IN CYNOMOLGUS MONKEYS PREEXPOSED TO SUBINFECTIOUSDOSES OF SIVSM OR HIV-2
Authors: BIBERFELD G MAKITALO B PUTKONEN P BOTTIGER D RUD E THORSTENSSON R
Citation: G. Biberfeld et al., PROTECTIVE IMMUNITY IN CYNOMOLGUS MONKEYS PREEXPOSED TO SUBINFECTIOUSDOSES OF SIVSM OR HIV-2, AIDS research and human retroviruses, 11, 1995, pp. 137-137
VIRUS-SPECIFIC IMMUNITY IN CYNOMOLGUS MONKEYS EXPOSED TO A LOW-DOSE OF SIVSM
Authors: THORSTENSSON R MAKITALO B BOTTIGER D RUD E BIBERFELD G PUTKONEN P
Citation: R. Thorstensson et al., VIRUS-SPECIFIC IMMUNITY IN CYNOMOLGUS MONKEYS EXPOSED TO A LOW-DOSE OF SIVSM, Journal of cellular biochemistry, 1995, pp. 227-227
PROTECTION OF MACAQUES AGAINST SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION WITH INACTIVATED VACCINES - COMPARISON OF ADJUVANTS, DOSES AND CHALLENGE VIRUSES
Authors: DORMONT D LEGRAND R CRANAGE M GREENAWAY P HUNSMANN G STAHLHENNIG C ROSSI G VERANI P STOTT J KITCHIN P OSTERHAUS A DEVRIES P KURTH R NORLEY S HEENEY J BIBERFELD G PUTKONEN P
Citation: D. Dormont et al., PROTECTION OF MACAQUES AGAINST SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION WITH INACTIVATED VACCINES - COMPARISON OF ADJUVANTS, DOSES AND CHALLENGE VIRUSES, Vaccine, 13(3), 1995, pp. 295-300
HETEROLOGOUS HIV-2 CHALLENGE OF RHESUS-MONKEYS IMMUNIZED WITH RECOMBINANT VACCINIA VIRUSES AND PURIFIED RECOMBINANT HIV-2 PROTEINS
Authors: VOGT G LEGRAND R VASLIN B BOUSSIN F AUBOYER MHB RIVIERE Y PUTKONEN P SONIGO P KIENY MP GIRARD M DORMONT D
Citation: G. Vogt et al., HETEROLOGOUS HIV-2 CHALLENGE OF RHESUS-MONKEYS IMMUNIZED WITH RECOMBINANT VACCINIA VIRUSES AND PURIFIED RECOMBINANT HIV-2 PROTEINS, Vaccine, 13(2), 1995, pp. 202-208
CHIMERIC MACAQUE HUMAN FAB MOLECULES NEUTRALIZE SIMIAN IMMUNODEFICIENCY VIRUS
Authors: SAMUELSSON A CHIODI F OHMAN P PUTKONEN P NORRBY E PERSSON MAA
Citation: A. Samuelsson et al., CHIMERIC MACAQUE HUMAN FAB MOLECULES NEUTRALIZE SIMIAN IMMUNODEFICIENCY VIRUS, Virology, 207(2), 1995, pp. 495-502
B-CELL LYMPHOMAGENESIS IN SIV-IMMUNOSUPPRESSED CYNOMOLGUS MONKEYS
Authors: REZIKYAN S KAAYA EE EKMAN M VOEVODIN AF FEICHTINGER H PUTKONEN P CASTANOSVELEZ E BIBERFELD G BIBERFELD P
Citation: S. Rezikyan et al., B-CELL LYMPHOMAGENESIS IN SIV-IMMUNOSUPPRESSED CYNOMOLGUS MONKEYS, International journal of cancer, 61(4), 1995, pp. 574-579
LONG-STANDING PROTECTION OF MACAQUES AGAINST CELL-FREE HIV-2 WITH A HIV-2 ISCOM VACCINE
Authors: PUTKONEN P BJORLING E AKERBLOM L THORSTENSSON R LOVGREN K BENTHIN L CHIODI F MOREIN B BIBERFELD G NORRBY E WIGZELL H
Citation: P. Putkonen et al., LONG-STANDING PROTECTION OF MACAQUES AGAINST CELL-FREE HIV-2 WITH A HIV-2 ISCOM VACCINE, Journal of acquired immune deficiency syndromes, 7(6), 1994, pp. 551-559
VACCINATION OF CYNOMOLGUS MONKEYS WITH A CANARY POX HIV-2 VACCINE
Authors: BIBERFELD G PUTKONEN P ANDERSSON S MAKITALO B THORSTENSSON R FRANCHINI G TARTAGLIA J PAOLETTI E
Citation: G. Biberfeld et al., VACCINATION OF CYNOMOLGUS MONKEYS WITH A CANARY POX HIV-2 VACCINE, AIDS research and human retroviruses, 10, 1994, pp. 190000136-190000136
IMMUNIZATION OF CYNOMOLGUS MONKEYS WITH A SUBUNIT HIV-2 VACCINE
Authors: BIBERFELD G PUTKONEN P THORSTENSSON R GILLJAM G AKERBLOM L MOREIN B
Citation: G. Biberfeld et al., IMMUNIZATION OF CYNOMOLGUS MONKEYS WITH A SUBUNIT HIV-2 VACCINE, AIDS research and human retroviruses, 10, 1994, pp. 190000043-190000043
Risultati: 1-25 | 26-41